The market for injection devices such as autoinjectors and pens is rapidly growing. Factors in this expansion include the trend toward self-medication, the increasing incidence of chronic diseases, and a growing biotech sector. The sophisticated, innovative labeling solutions often needed in this sector drove Schreiner MediPharm to develop additional features for its Autoinjector Labels.
Schreiner MediPharm is a global provider of specialty pharmaceutical labeling. Its newest concept for its Autoinjector Labels combines first-opening protection with an anti-recapping function and dust protection. The label wraps around the autoinjector, including the cap, providing effective dust and dirt protection before the device is initially opened. An integrated perforation clearly indicates that the label has been opened.
The label is positioned in a way that prevents undetected recapping of the autoinjector for illegal reuse. Other possible features include:
• A hologram for counterfeiting protection
• Inspection windows with an anti-UV varnish coating, to protect light-sensitive active drugs
• A room temperature indicator
• An anti-slip varnish for enhanced grip and safe handling
Injection treatment aids for such serious conditions as diabetes, rheumatoid arthritis, anaphylactic shock and multiple sclerosis need to be easy and safe in use, particularly for health- and motor-impaired patients. Schreiner MediPharm’s functional labels provide valuable assistance that address a variety of needs.
